UA103664C2 - 5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ - Google Patents

5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ

Info

Publication number
UA103664C2
UA103664C2 UAA201112311A UAA201112311A UA103664C2 UA 103664 C2 UA103664 C2 UA 103664C2 UA A201112311 A UAA201112311 A UA A201112311A UA A201112311 A UAA201112311 A UA A201112311A UA 103664 C2 UA103664 C2 UA 103664C2
Authority
UA
Ukraine
Prior art keywords
glomerulosclerosis
proteinuria
treatment
renal failure
derivatives useful
Prior art date
Application number
UAA201112311A
Other languages
English (en)
Ukrainian (uk)
Inventor
Патриция Феррари
Джузеппе Бьянки
Мара Ферранди
Original Assignee
Сигма-Тау Индустрие Фармасьютике Риуните С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. filed Critical Сигма-Тау Индустрие Фармасьютике Риуните С.П.А.
Publication of UA103664C2 publication Critical patent/UA103664C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение касается применения соединения формулы (I)(I),где значения символов раскрыты в тексте; как антипротеинурического средства, антигломерулосклеротического средства или как средства для лечения почечной недостаточности.
UAA201112311A 2009-03-23 2010-03-18 5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ UA103664C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09155834 2009-03-23
PCT/EP2010/053571 WO2010108855A1 (en) 2009-03-23 2010-03-18 5-β, 14-β-ANDROSTANE DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEINURIA, GLOMERULOSCLEROSIS AND RENAL FAILURE

Publications (1)

Publication Number Publication Date
UA103664C2 true UA103664C2 (ru) 2013-11-11

Family

ID=40622086

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201112311A UA103664C2 (ru) 2009-03-23 2010-03-18 5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ

Country Status (21)

Country Link
US (2) US20120028945A1 (ru)
EP (1) EP2411015B1 (ru)
JP (1) JP5738267B2 (ru)
KR (1) KR101656797B1 (ru)
CN (1) CN102361643B (ru)
AU (1) AU2010227644B2 (ru)
BR (1) BRPI1012240A2 (ru)
CA (1) CA2754642C (ru)
DK (1) DK2411015T3 (ru)
EA (1) EA019929B1 (ru)
ES (1) ES2559005T3 (ru)
HU (1) HUE027408T2 (ru)
IL (1) IL214477A (ru)
MX (1) MX2011009321A (ru)
NZ (1) NZ594412A (ru)
PL (1) PL2411015T3 (ru)
PT (1) PT2411015E (ru)
SG (2) SG174260A1 (ru)
UA (1) UA103664C2 (ru)
WO (1) WO2010108855A1 (ru)
ZA (1) ZA201107647B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012004559A (es) * 2009-10-19 2012-12-05 Rostaquo S P A Metodos y sistemas para tratamiento farmacogenomico de condiciones cardiovasculares.
CN102940640A (zh) * 2012-12-06 2013-02-27 中国生命药物治疗有限公司 罗他夫辛在制备治疗基因缺陷型原发性高血压的药物中的用途
CN105078954A (zh) * 2015-08-20 2015-11-25 南京华宽信息咨询中心 一种治疗急性肾衰药物及其应用
CN108152432B (zh) * 2017-12-29 2020-11-20 兆科药业（合肥）有限公司 一种罗他夫辛片高效液相检测方法
US11337988B2 (en) 2018-09-27 2022-05-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of ouabain antagonists to inhibit viral infection
DK3805243T3 (da) * 2019-10-09 2024-01-02 Windtree Therapeutics Inc Androstanderivater med aktivitet som rene eller hovedsageligt rene stimulatorer af serca2a til behandling af hjertesvigt

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
DE4232681C2 (de) 1992-09-29 1994-11-24 Sigma Tau Ind Farmaceuti 17-Phenyl- und 17-Furyl-14beta,5alpha-androstan- und androsten- Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
DE4232638C2 (de) 1992-09-29 1994-11-17 Sigma Tau Ind Farmaceuti 17-Phenyl-5beta-14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
TWI389917B (zh) * 2006-04-13 2013-03-21 Sigma Tau Ind Farmaceuti 作為心血管疾病治療藥物的雄甾烷與雄甾烯之氮雜環烷基衍生物
TWI392682B (zh) * 2006-04-13 2013-04-11 Sigma Tau Ind Farmaceuti 作為心血管疾病的治療藥物之雄甾烷和雄甾烯的胺基衍生物
TWI372762B (en) * 2006-06-23 2012-09-21 Sigma Tau Ind Farmaceuti Amino derivatives of b-homoandrostanes and b-heteroandrostanes
KR101530019B1 (ko) * 2007-06-07 2015-06-18 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 혈관성형술 또는 동맥내막절제술 후 재협착 및 장기 섬유증으로 인한 질환의 치료에 유용한 5베타, 14베타-안드로스테인 유도체

Also Published As

Publication number Publication date
KR20110133027A (ko) 2011-12-09
CA2754642C (en) 2016-11-08
CN102361643A (zh) 2012-02-22
PT2411015E (pt) 2016-02-26
US20120028945A1 (en) 2012-02-02
IL214477A0 (en) 2011-09-27
IL214477A (en) 2017-04-30
US20160251392A1 (en) 2016-09-01
AU2010227644B2 (en) 2016-05-19
WO2010108855A1 (en) 2010-09-30
EA019929B1 (ru) 2014-07-30
EP2411015B1 (en) 2015-12-23
NZ594412A (en) 2013-10-25
KR101656797B1 (ko) 2016-09-12
MX2011009321A (es) 2011-10-03
AU2010227644A1 (en) 2011-09-01
BRPI1012240A2 (pt) 2018-06-12
JP2012521383A (ja) 2012-09-13
ZA201107647B (en) 2012-07-25
EA201171155A1 (ru) 2012-03-30
JP5738267B2 (ja) 2015-06-24
SG174260A1 (en) 2011-10-28
PL2411015T3 (pl) 2016-05-31
HUE027408T2 (en) 2016-10-28
SG2014010912A (en) 2014-06-27
DK2411015T3 (en) 2016-02-08
ES2559005T3 (es) 2016-02-10
US9868757B2 (en) 2018-01-16
EP2411015A1 (en) 2012-02-01
CN102361643B (zh) 2016-05-18
CA2754642A1 (en) 2010-09-30

Similar Documents

Publication Publication Date Title
UA106748C2 (ru) Производные пролина как ингибиторы катепсина
AP2011005740A0 (en) Pirfenidone treatment for patients with a typical liver function.
AP2011005754A0 (en) Processing biomas.
AP2011005815A0 (en) Processing biomass.
TW201129938A (en) Personal mapping system
AP2011006029A0 (en) Processing biomass.
AP2012006216A0 (en) Benzimidazole-imidazole derivatives.
ZA200908903B (en) Safety luer connection
ZA201108756B (en) Systems,methods and compositions for optimizing tissue and cell enriched grafts
AP2010005481A0 (en) Processing biomass.
AP2011005703A0 (en) Processing biomass.
IL217208A (en) History of cryptophycin, critophycin conjugates, processes for their preparation, and their use as anticancer agents
AU333673S (en) Bar chair
PL2454426T3 (pl) Układ rusztowania oraz złącze, podłużnica rusztowania i stojak
UA103664C2 (ru) 5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ
PH12015502178A1 (en) Pyridinylpyrazoloquinoline compound
AP2012006292A0 (en) Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection.
MX2012014796A (es) Proceso para preparar 4-hidroxipiridinas.
AP2011005868A0 (en) Modular core orientation system.
MX348786B (es) Agentes osmoticos de polisacarido esterificado.
MX2013009456A (es) Compuestos de azufre aromaticos sustituidos y metodos para su uso.
PL2519504T3 (pl) Nowe drugorzędowe pochodne 8-hydroksychinolino-7-karboksyamidu
WO2010112589A3 (de) Schnittschablone aus keramik
WO2011006097A3 (en) Methods For Treating Toxicity
LU91562B1 (en) Hydroquinone derivatives.